| Date Filed | Type | Description |
| 08/22/2023 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 15,335 shares
@ $1.3037, valued at
$20k
|
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Duncan Gregory Scott (CEO) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 480,000 options to buy
@ $0.2789, valued at
$133.9k
|
|
| 12/14/2022 |
4
| Walsh Angela (SVP OF FINANCE) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.2789, valued at
$22.3k
|
|
| 12/14/2022 |
4
| Grosswald Ralph (SVP OF OPERATIONS) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.2789, valued at
$22.3k
|
|
| 12/14/2022 |
4
| Gendreau Roger Michael (CHIEF MEDICAL OFFICER) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.2789, valued at
$22.3k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 5,250 options to buy
@ $4.23, valued at
$22.2k
|
|
| 06/30/2022 |
4
| Burch Richard Alan (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 5,250 options to buy
@ $4.23, valued at
$22.2k
|
|
| 06/30/2022 |
4
| Keefer David R (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 5,250 options to buy
@ $4.23, valued at
$22.2k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| De La Rosa Abel (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 5,250 options to buy
@ $4.23, valued at
$22.2k
|
|
| 06/30/2022 |
4
| Gendreau Roger Michael (CHIEF MEDICAL OFFICER) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.23, valued at
$169.2k
|
|
| 06/30/2022 |
4
| Grosswald Ralph (SVP OF OPERATIONS) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.23, valued at
$169.2k
|
|
| 06/30/2022 |
4
| Walsh Angela (SVP OF FINANCE) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.23, valued at
$169.2k
|
|
| 06/30/2022 |
4
| Duncan Gregory Scott (CEO) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $4.23, valued at
$380.7k
|
|
| 05/24/2022 |
4
| Walsh Angela (SVP OF FINANCE) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $4.575, valued at
$9.2k
|
|
| 05/24/2022 |
4
| Duncan Gregory Scott (CEO) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 7,500 shares
@ $4.52, valued at
$33.9k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 241 shares
@ $4.5, valued at
$1.1k
|
|
| 05/18/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 13,450 shares
@ $4.3802, valued at
$58.9k
|
|
| 03/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 4,180 shares
@ $5.9803, valued at
$25k
|
|
| 01/07/2022 |
4
| De La Rosa Abel (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $5.896, valued at
$23.6k
|
|
| 01/07/2022 |
4
| Whitley Richard James (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 1,800 shares
@ $5.72, valued at
$10.3k
|
|
| 01/05/2022 |
4
| Keefer David R (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $5.795, valued at
$29k
|
|
| 01/04/2022 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 2,215 shares
@ $5.4329, valued at
$12k
|
|
| 01/04/2022 |
4
| Thomas John C (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $5.65, valued at
$5.7k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2021 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 8,827 shares
@ $5.6641, valued at
$50k
|
|
| 12/22/2021 |
4
| Duncan Gregory Scott (CEO) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $5.523, valued at
$27.6k
|
|
| 07/09/2021 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 942 shares
@ $6.317, valued at
$6k
|
|
| 06/23/2021 |
4
| Pridgen William (Director) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 7,875 options to buy
@ $6.5, valued at
$51.2k
|
|
|